Antacids Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Nov-2019 | List of Tables : 24 | List of Figures : 95 | No. of Pages : 170 | Report Code : FACT4328MR | Format : ppt pdf Excel Word

Online Pharmacies Drive Growth in North America, while Europe Antacids Market Retains Pole Position

Several aspects—ranging from unhealthy food habits, sedentary lifestyles, to regular intake of medicines to treat high blood pressure—increase acid levels in the stomach, which inadvertently increases the demand for antacids. The recent past has witnessed wide availability of antacids in numerous formats, which are resonating well with consumers. Manufacturers in the antacids market are approaching drug formulation techniques through consumer-centric means, in the form of chewable and flavored tablets, to score well in convenience regards. On the back of these factors, the exhaustive study by Fact.MR pegs the global antacids markets to soar to ~US$ 19 Bn by 2025.

Lenient legislations regarding the over-the-counter (OTC) availability of antacids are complementing the penetration of antacids through retail pharmacies, convenience stores, and hospital pharmacies. In the future, market players will increase their budgets on research & development initiatives to differentiate their products by developing effective antacids.

global antacids market intensity mapping

For detailed regional analysis, request a sample copy of the report here.

Growing Popularity of Natural Therapeutics to Limit Sales Opportunities

Proton pump inhibitors (PPIs) are considered as standard antacids for the treatment of gastroesophageal reflux disease (also known as GERD). However, the prolonged use of these drugs—1 year or longer—is found to have an adverse impact on the kidneys and absorption level of vitamin B12. Besides this, high doses of PPIs on a regular basis could increase the risk of spine, wrist, or hip fractures. As a result, rising awareness regarding the negative impact of PPIs is projected to reflect on the increasing production of H2 antagonist and acid neutralizers, which are emerging as strong alternatives for PPIs in the antacids market.

Despite the availability of effective substitutes for PPIs, consumers are looking at natural therapeutics to eliminate any grade of side-effect caused by antibiotics, which has been gaining ground to Ayurveda and Chinese treatments. These treatments require cost-effective household ingredients to develop therapeutics, in order to cure acid reflux. Besides, the increasing inclination of consumers towards natural treatments could derail steady sales opportunities for players in the antacids market.

Why Increasing Investments in Gummy and Melt-in-Mouth Formulations is Deemed Lucrative

Convenience is a significant feature leading to an increase in the demand for antacids in the tablet format, which is expected to generate sales tantamount to ~US$ 13 Bn by 2025. Tablets will remain the leading choice of consumers suffering from GERD, on the backdrop of their administered dosage, ease of consumption, and storage convenience. The availability of leading drug classes in the tablet format is further adding sheen to the growing popularity of tablets in the antacids market.

However, as manufacturers strive to reposition their brand identity, antacids in melt-in-mouth micro-granules and gummies are gaining traction. During the forecast period, these formulations are projected to record a marginal rise at a CAGR of ~5% in the antacids market.

global antacids market share

For more information, request a sample copy of the report here.

Crucial Distribution Channels to Target across Key Regions

On a global level, players in the antacids market are targeting distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the over-the-counter availability of antacids is shifting lucrative sales opportunities from hospital pharmacies to others. The unprecedented growth of e-Commerce channels coupled with the convenience of home delivery of therapeutics is turning online pharmacies as a standard distribution channel for antacids. However, the purchase behavior of consumers varies from region-to-region.

Europe is the leading antacids market, estimated to account for one-third of the total market share in 2025. Given the high penetration of smartphones and the popularity of the online-shopping culture, players operating in the antacids market in this region are recording a majority of sales through online pharmacies. The prominence of online pharmacies is also likely to remain high in the North American antacids market, given the concentration of advanced pharmaceutical laboratories and availability of high-speed Internet connection, which encourages more sales through online channels.

In contrast to this, a significant chunk of revenue generated by the Asia Pacific antacids market is attributable to retail pharmacies; however, penetration of the smartphone culture and improvements in telecom services will create sales opportunities from online pharmacies, in the near future. In a nutshell, players in the antacids market targeting developed regions can partner with online pharmacies, while those looking at developing regions can collaborate with retail pharmacies, and gradually move towards online channels.

Request research methodology of this report.

Antacids Market – Scope of the Report

Fact.MR’s report on the antacids market provides forecast details and an all-inclusive outlook on the growth and development of the landscape. With historical data from 2017 to 2019, estimated data for 2020, and forecast data up to 2025, in terms of revenue and volume, this study has information on the trends and how they impact the antacids market over the forecast period. This research report offers data on the key trends, along with the micro and macro-economic indicators that have an impact on the antacids market. This report sheds light on how these trends are expected to affect every component in the value chain, from the suppliers to the end users, and how they are likely to influence the market as a whole.

This report is a study on the current scenario, on end user’s requirements, new developments, and the issues faced by the supply chain as a whole in the antacids landscape. It is meant to provide readers with an exclusive view of the antacids market as a whole, and a detailed understanding of the major players in the antacids landscape. This analysis of key players includes data and analytics on product developments and market presence, along with a comparative assessment of the companies, on a variety of parameters.

Antacids Market – Segmentation Assessment

The global antacids market is segmented based on

Drug Class

Formulation

Distribution Channel

Region

Proton Pump Inhibitors

Tablets

 

Hospital Pharmacies

North America

  • US
  • Canada

H2 Antagonists

Liquid

Retain Pharmacies

Europe

  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Acid Neutralizers

Powder

Others

Asia Pacific

  • India
  • China
  • Japan
  • Australia and New Zealand
  • Rest of APAC

 

Others

 

Latin America

  • Brazil
  • Mexico
  • Rest of LATAM

 

 

 

Middle East and North Africa

  • GCC Countries
  • South Africa
  • Rest of Africa

 

 

 

 

This study on the global antacids market has drug class, formulation, distribution channel, and region-specific data, along with market size valuation. It also has an in-depth forecast price point assessment of the same. The price index and the impact analysis of key regional and country-wise dynamics, also mentioned in the antacids market report, have been obtained through quotes from stakeholders and experts in the global antacids market. An in-depth analysis on the Y-o-Y growth projections of the antacids market is also included in this report.

Antacids Market – Research Methodology

Data presented in this report on the global antacids market, pertaining to regional- and country-level information of the segments, is estimated though a combination of primary and secondary research, across countries and regions. This collated information is analysed using both, the top-down and the bottom-up approach, along with Porter’s Five Forces analysis, and an analysis of the market attractiveness as well.

This Fact.MR global antacids market’s competition scenario analysis is based on historical data and on current trends in the market, and insights obtained through secondary research. The system of data triangulation is also used for the cross-checking of the collected and analysed data, from both, the supply and the demand side of the antacids market.

For the assessment of market size and volume estimations, data has been gathered from the revenues of leading players, coupled with their production capacities. There are also other qualitative findings and perspectives gathered from interviews with people within the market, including Plant Managers, Business Development Managers / Executives, and CEOs, which has been added to this report on the antacids market. This information has been adhered to by the analysts while developing this report on the global antacids market. Secondary research is leveraged for ascertaining the overall size of the antacids market.

The market viewpoint that is offered in this report on the antacids market considers the impact of the macro-economic factors that are expected to influence the progress of the market. The study includes a section on global pricing analysis, restraint analysis, and an opportunity analysis of the antacids market as well.

This report is designed to serve as an authentic and informative resource, enabling readers to make data-based decisions on the future of businesses in the global antacids market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Antacids Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Antacids Market Value (US$ Mn) Forecast, 2020 - 2025

    4.5. Porter’s Five Force Analysis

    4.6. Value Chain Analysis

    4.7. Market Outlook

5. Global Antacids Market Analysis and Forecasts, By Drug Class 

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        5.4.1. Proton pump inhibitors

        5.4.2. H2 Antagonist

        5.4.3. Acid neutralizers

    5.5. Market Attractiveness By Drug Class 

6. Global Antacids Market Analysis and Forecasts, By Formulation 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        6.4.1. Tablet

        6.4.2. Liquid

        6.4.3. Powder

        6.4.4. Others

    6.5. Market Attractiveness By Formulation 

7. Global Antacids Market Analysis and Forecasts, By Distribution Channel 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        7.4.1. Hospital Pharmacies

        7.4.2. Retail Pharmacies

        7.4.3. Others

    7.5. Market Attractiveness By Distribution Channel 

8. Global Antacids Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value (US$ Mn) Forecast By Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East and Africa 

    8.3. Market Attractiveness By Country/Region

9. North America Antacids Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Key Trends

    9.2. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        9.2.1. Proton pump inhibitors

        9.2.2. H2 Antagonist

        9.2.3. Acid neutralizers

    9.3. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        9.3.1. Tablet

        9.3.2. Liquid

        9.3.3. Powder

        9.3.4. Others

    9.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        9.4.1. Hospital Pharmacies

        9.4.2. Retail Pharmacies

        9.4.3. Others

    9.5. Market Value (US$ Mn) Forecast By Country, 2020-2025

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis 

        9.6.1. By Drug Class 

        9.6.2. By Formulation 

        9.6.3. By Distribution Channel 

        9.6.4. By Country

10. Europe Antacids Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Key Trends

    10.2. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        10.2.1. Proton pump inhibitors

        10.2.2. H2 Antagonist

        10.2.3. Acid neutralizers

    10.3. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        10.3.1. Tablet

        10.3.2. Liquid

        10.3.3. Powder

        10.3.4. Others

    10.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Others

    10.5. Market Value (US$ Mn) Forecast By Country, 2020-2025

        10.5.1. U.K.

        10.5.2. Germany

        10.5.3. France 

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis 

        10.6.1. By Drug Class 

        10.6.2. By Formulation 

        10.6.3. By Distribution Channel 

        10.6.4. By Country

11. Asia Pacific Antacids Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Key Trends

    11.2. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        11.2.1. Proton pump inhibitors

        11.2.2. H2 Antagonist

        11.2.3. Acid neutralizers

    11.3. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        11.3.1. Tablet

        11.3.2. Liquid

        11.3.3. Powder

        11.3.4. Others

    11.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Others

    11.5. Market Value (US$ Mn) Forecast By Country, 2020-2025

        11.5.1. India 

        11.5.2. China

        11.5.3. Japan

        11.5.4. Australia & New Zealand 

        11.5.5. Rest of Aisa Pacific

    11.6. Market Attractiveness Analysis 

        11.6.1. By Drug Class 

        11.6.2. By Formulation 

        11.6.3. By Distribution Channel 

        11.6.4. By Country

12. Latin America Antacids Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Key Trends

    12.2. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        12.2.1. Proton pump inhibitors

        12.2.2. H2 Antagonist

        12.2.3. Acid neutralizers

    12.3. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        12.3.1. Tablet

        12.3.2. Liquid

        12.3.3. Powder

        12.3.4. Others

    12.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Others

    12.5. Market Value (US$ Mn) Forecast By Country, 2020-2025

        12.5.1. Brazil 

        12.5.2. Mexico 

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis 

        12.6.1. By Drug Class 

        12.6.2. By Formulation 

        12.6.3. By Distribution Channel 

        12.6.4. By Country

13. Middle East and Africa Antacids Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

        13.1.2. Key Trends

    13.2. Market Value (US$ Mn) Forecast By Drug Class, 2020-2025

        13.2.1. Proton pump inhibitors

        13.2.2. H2 Antagonist

        13.2.3. Acid neutralizers

    13.3. Market Value (US$ Mn) Forecast By Formulation, 2020-2025

        13.3.1. Tablet

        13.3.2. Liquid

        13.3.3. Powder

        13.3.4. Others

    13.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2020-2025

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Others

    13.5. Market Value (US$ Mn) Forecast By Country, 2020-2025

        13.5.1. South Africa 

        13.5.2. Saudi Arabia 

        13.5.3. Rest of MEA

    13.6. Market Attractiveness Analysis 

        13.6.1. By Drug Class 

        13.6.2. By Formulation 

        13.6.3. By Distribution Channel 

        13.6.4. By Country

14. Competition Landscape

    14.1. Market Players

    14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        14.2.1. AstraZeneca

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Business Overview

            14.2.1.3. Product Portfolio 

            14.2.1.4. Financial Overview 

            14.2.1.5. SWOT Analysis 

            14.2.1.6. Strategic overview

        14.2.2. Bayer AG 

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Business Overview

            14.2.2.3. Product Portfolio 

            14.2.2.4. Financial Overview 

            14.2.2.5. SWOT Analysis 

            14.2.2.6. Strategic overview

        14.2.3. Boehringer Ingelheim GmbH

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Business Overview

            14.2.3.3. Product Portfolio 

            14.2.3.4. Financial Overview 

            14.2.3.5. SWOT Analysis 

            14.2.3.6. Strategic overview 

        14.2.4. Dr. Reddy’s Laboratories Ltd.

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Business Overview

            14.2.4.3. Product Portfolio 

            14.2.4.4. Financial Overview 

            14.2.4.5. SWOT Analysis 

            14.2.4.6. Strategic overview

        14.2.5. GlaxoSmithKline plc

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Business Overview

            14.2.5.3. Product Portfolio 

            14.2.5.4. Financial Overview 

            14.2.5.5. SWOT Analysis 

            14.2.5.6. Strategic overview

        14.2.6. Johnson & Johnson

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Business Overview

            14.2.6.3. Product Portfolio 

            14.2.6.4. Financial Overview 

            14.2.6.5. SWOT Analysis 

            14.2.6.6. Strategic overview 

        14.2.7. Pfizer Inc. 

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Business Overview

            14.2.7.3. Product Portfolio 

            14.2.7.4. Financial Overview 

            14.2.7.5. SWOT Analysis 

            14.2.7.6. Strategic overview

        14.2.8. Procter & Gamble

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Business Overview

            14.2.8.3. Product Portfolio 

            14.2.8.4. Financial Overview 

            14.2.8.5. SWOT Analysis 

            14.2.8.6. Strategic overview

        14.2.9. Reckitt Benckiser Group plc

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Business Overview

            14.2.9.3. Product Portfolio 

            14.2.9.4. Financial Overview 

            14.2.9.5. SWOT Analysis 

            14.2.9.6. Strategic overview

        14.2.10. Sanofi

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Business Overview

            14.2.10.3. Product Portfolio 

            14.2.10.4. Financial Overview 

            14.2.10.5. SWOT Analysis 

            14.2.10.6. Strategic overview

        14.2.11. Sun Pharmaceuticals Ltd

            14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.11.2. Business Overview

            14.2.11.3. Product Portfolio 

            14.2.11.4. Financial Overview 

            14.2.11.5. SWOT Analysis 

            14.2.11.6. Strategic overview 

        14.2.12. Takeda Pharmaceutical

            14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.12.2. Business Overview

            14.2.12.3. Product Portfolio 

            14.2.12.4. Financial Overview 

            14.2.12.5. SWOT Analysis 

            14.2.12.6. Strategic overview

        14.2.13. Valeant Pharmaceuticals International, Inc.

            14.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.13.2. Business Overview

            14.2.13.3. Product Portfolio 

            14.2.13.4. Financial Overview 

            14.2.13.5. SWOT Analysis 

            14.2.13.6. Strategic overview

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Antacids Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025